Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chieko Ishiguro

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|September 18, 2025
Trends in the use of validated claims-based algorithms in Japanese post-marketing database studiesChieko Ishiguro, Takahiro Nonaka
Journal of Epidemiology|December 7, 2025
The Claims data Learning & Enhancing for Algorithm Refinement (CLEAR) Study: Overview of the Study Design and Baseline ProfileHaruhisa Fukuda, Megumi Maeda, Chieko Ishiguro
Therapeutic Innovation & Regulatory Science|July 31, 2025
Longitudinal Descriptive Analysis of Dynamic Changes in Safety Concerns in Japanese Risk Management Plans for Medicinal Products Over 8 Years After ApprovalChieko Ishiguro, Mahiro Sazawa, Takahiro Nonaka
Journal of Pharmaceutical Policy and Practice|July 8, 2025
Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine productsChieko Ishiguro, Yasutomo Teshima, Harumasa Nakamura
Pharmacoepidemiology and Drug Safety|April 17, 2014
Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to additionNorio Tamura, Chieko Ishiguro, Tsutomu Matsuda
Journal of Biochemistry|December 16, 2004
Increased A:T-->C:G mutations in the mutT strain upon 8-hydroxy-dGTP treatment: direct evidence for MutT involvement in the prevention of mutations by oxidized dGTPHiroyuki Kamiya, Chieko Ishiguro, Hideyoshi Harashima
Vaccine|July 19, 2022
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: The LIFE-VENUS StudyWataru Mimura, Chieko Ishiguro, Haruhisa Fukuda
Vaccine|September 12, 2022
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) studyChieko Ishiguro, Wataru Mimura, Fumiko Murata, et al.
Pharmacoepidemiology and Drug Safety|September 9, 2014
Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRDChieko Ishiguro, Xi Wang, Lin Li, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agencyChieko Ishiguro, Takashi Misu, Eiko Iwasa, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|September 18, 2025
Trends in the use of validated claims-based algorithms in Japanese post-marketing database studiesChieko Ishiguro, Takahiro Nonaka
Journal of Epidemiology|December 7, 2025
The Claims data Learning & Enhancing for Algorithm Refinement (CLEAR) Study: Overview of the Study Design and Baseline ProfileHaruhisa Fukuda, Megumi Maeda, Chieko Ishiguro
Therapeutic Innovation & Regulatory Science|July 31, 2025
Longitudinal Descriptive Analysis of Dynamic Changes in Safety Concerns in Japanese Risk Management Plans for Medicinal Products Over 8 Years After ApprovalChieko Ishiguro, Mahiro Sazawa, Takahiro Nonaka
Journal of Pharmaceutical Policy and Practice|July 8, 2025
Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine productsChieko Ishiguro, Yasutomo Teshima, Harumasa Nakamura
Pharmacoepidemiology and Drug Safety|April 17, 2014
Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to additionNorio Tamura, Chieko Ishiguro, Tsutomu Matsuda
Journal of Biochemistry|December 16, 2004
Increased A:T-->C:G mutations in the mutT strain upon 8-hydroxy-dGTP treatment: direct evidence for MutT involvement in the prevention of mutations by oxidized dGTPHiroyuki Kamiya, Chieko Ishiguro, Hideyoshi Harashima
Vaccine|July 19, 2022
Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: The LIFE-VENUS StudyWataru Mimura, Chieko Ishiguro, Haruhisa Fukuda
Vaccine|September 12, 2022
Development and application of a Japanese vaccine database for comparative assessments in the post-authorization phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) studyChieko Ishiguro, Wataru Mimura, Fumiko Murata, et al.
Pharmacoepidemiology and Drug Safety|September 9, 2014
Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRDChieko Ishiguro, Xi Wang, Lin Li, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agencyChieko Ishiguro, Takashi Misu, Eiko Iwasa, et al.
Pageof 6